A case of ACTH-independent bilateral macronodular adrenal hyperplasia and severe congestive heart failure

D Suri1, M Alonso, R E Weiss

  • 1Department of Medicine, University of Chicago, Chicago, IL 60645, USA.

Insights

This study details a unique case of Cushing's syndrome (CS) caused by bilateral macronodular adrenal hyperplasia (AIMAH). Aberrant adrenal receptors, potentially linked to heart failure, led to increased cortisol secretion.

Area of Science:

  • Endocrinology
  • Cardiology
  • Molecular Biology

Background:

  • ACTH-independent bilateral macronodular adrenal hyperplasia (AIMAH) is a rare cause of Cushing's syndrome (CS).
  • AIMAH pathogenesis involves aberrant adrenal receptors mediating abnormal hormone secretion.
  • Congestive heart failure (CHF) can activate the renin-angiotensin system, increasing angiotensin II (AT-II) levels.

Observation:

  • A patient with CS due to AIMAH and severe Class IV CHF presented with abnormal responses to ACTH and postural changes.
  • Clinical testing suggested aberrant adrenal receptors for ACTH, vasopressin, catecholamines, or AT-II.
  • Adrenal tissue analysis revealed an eight-fold increase in melanocortin 2 receptor (MC2-R) expression.

Findings:

  • Increased MC2-R expression correlated with elevated cortisol and aldosterone following ACTH administration.
  • The study proposes that severe CHF-induced AT-II elevation may have upregulated MC2-R expression.
  • This suggests a novel mechanism linking CHF, AT-II, and AIMAH development.

Implications:

  • This case may elucidate a previously unrecognized pathway for AIMAH development in CS.
  • Understanding aberrant receptor function in AIMAH could lead to targeted therapies.
  • The interplay between cardiac function and adrenal steroidogenesis warrants further investigation.

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...